“Effectiveness of Casirivimab-Imdevimab and Sotrovimab Monoclonal Antibody Treatment Among High-Risk Patients With Sars-Cov-2 Infection: A Real-World Experience”. Archives of Clinical and Biomedical Research 7, no. 3 (May 10, 2023): 325–336. Accessed September 17, 2026. https://fortunejournals.org/ojs/index.php/acbr/article/view/15015.